URGN Earnings Urogen Pharma Ltd.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.47 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | -3.19 | 2026-03-02 | 10-K |
| Q3 2025 | 2025-09-30 | -2.66 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.97 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.92 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | -2.96 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -2.15 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.69 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.87 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -3.55 | 2025-03-10 | 10-K |
| FY 2024 | 2023-09-30 | -2.89 | 2025-03-10 | 10-K |
| FY 2024 | 2023-06-30 | -2.33 | 2025-03-10 | 10-K |
| FY 2024 | 2023-03-31 | -1.30 | 2025-03-10 | 10-K |
| FY 2023 | 2022-12-31 | -4.81 | 2024-03-14 | 10-K |
| Q3 2023 | 2022-09-30 | -3.56 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.43 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.25 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -4.96 | 2023-03-24 | 10-K |
| Q3 2022 | 2021-09-30 | -3.69 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -2.34 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.